-
61.
公开(公告)号:AU2016219571A1
公开(公告)日:2016-09-08
申请号:AU2016219571
申请日:2016-08-23
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , CONNELLY PATRICK , ROWE WILLIAM , YOUNG CHRISTOPHER R , COSTACHE ADRIANA , KRAWIEC MARIUSZ , GONG YUCHUAN , FENG YUSHI , TRUDEAU MARTIN
IPC: A61K31/445
Abstract: The present invention relates to solid state forms of N-[2,4-bis(1,1 -dimethylethyl)-5 hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith.
-
公开(公告)号:AU2016216569A1
公开(公告)日:2016-09-01
申请号:AU2016216569
申请日:2016-08-16
Applicant: VERTEX PHARMA
Inventor: ROWE WILLIAM , HURTER PATRICIA , YOUNG CHRISTOPHER , DINEHART KIRK , OVERHOFF KIRK , GROOTENHUIS PETER D J , BOTFIELD MARTYN , GROSSI ALFREDO , VERWIJS MARINUS JACOBUS
IPC: A61K47/32
Abstract: The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3 carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
-
公开(公告)号:BR112012008082A2
公开(公告)日:2016-03-01
申请号:BR112012008082
申请日:2010-02-18
Applicant: VERTEX PHARMA
-
公开(公告)号:ZA201200722B
公开(公告)日:2013-05-29
申请号:ZA201200722
申请日:2012-01-30
Applicant: VERTEX PHARMA
Inventor: ROWE WILLIAM , HURTER PATRICIA , YOUNG CHRISTOPHER R , DINEHART KIRK , VERWIJS MARINUS JACOBUS , OVERHOFF KIRK , GROOTENHUIS PETER D J , BOTFIELD MARTYN , GROSSI ALFREDO , ZLOKARNIK GREGOR , VAN GOOR FREDRICK F
IPC: A61K20060101 , A61P20060101
Abstract: The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
-
公开(公告)号:AU2010282986A1
公开(公告)日:2012-02-16
申请号:AU2010282986
申请日:2010-02-18
Applicant: VERTEX PHARMA
Inventor: ROWE WILLIAM , HURTER PATRICIA , YOUNG CHRISTOPHER R , DINEHART KIRK , VERWIJS MARINUS JACOBUS , OVERHOFF KIRK , GROOTENHUIS PETER D J , BOTFIELD MARTYN , GROSSI ALFREDO , ZLOKARNIK GREGOR , VAN GOOR FREDRICK F
Abstract: The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis( 1, 1 -dimethylethyl)-5-hydroxyphenyl]- 1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
-
公开(公告)号:AU2009282419A2
公开(公告)日:2011-03-31
申请号:AU2009282419
申请日:2009-08-13
Applicant: VERTEX PHARMA
Inventor: ROWE WILLIAM , HURTER PATRICIA , YOUNG CHRISTOPHER , DINEHART KIRK , VERWIJS MARINUS JACOBUS , OVERHOFF KIRK , GROOTENHUIS PETER D J , BOTFIELD MARTYN , GROSSI ALFREDO
IPC: A61K47/32
Abstract: The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
-
公开(公告)号:DK2464337T4
公开(公告)日:2024-07-22
申请号:DK10708442
申请日:2010-02-18
Applicant: VERTEX PHARMA
-
公开(公告)号:ES2857152T3
公开(公告)日:2021-09-28
申请号:ES17204189
申请日:2009-08-13
Applicant: VERTEX PHARMA
Inventor: ROWE WILLIAM , HURTER PATRICIA , YOUNG CHRISTOPHER , DINEHART KIRK , VERWIJS MARINUS JACOBUS , OVERHOFF KIRK , GROOTENHUIS PETER D J , BOTFIELD MARTYN , GROSSI ALFREDO
Abstract: Una composición farmacéutica que comprende una dispersión sólida, en donde la dispersión sólida comprende: a) 80% en peso de N-[2,4-Bis(1,1-dimetiletil)-5-hidroxifenil]-1,4-dihidro-4-oxoquinolin-3-carboxamida (Compuesto 1) amorfa o sustancialmente amorfa por peso de la dispersión, en donde el Compuesto 1 sustancialmente amorfo comprende menos del 15% de Compuesto 1 cristalino, b) 19,5% en peso de succinato de acetato de hidroxipropilmetilcelulosa (HPMCAS) o copolímero de vinilpirrolidona/acetato de vinilo (PVP/VA) por peso de la dispersión, y c) 0,5% en peso de lauril sulfato de sodio (SLS) por peso de la dispersión.
-
公开(公告)号:HRP20210208T1
公开(公告)日:2021-03-19
申请号:HRP20210208
申请日:2021-02-05
Applicant: VERTEX PHARMA
-
公开(公告)号:SI3219705T1
公开(公告)日:2020-08-31
申请号:SI200632370
申请日:2006-12-28
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , GONG YUCHUAN , YOUNG CHRISTOPHER R , CONNELLY PATRICK , ROWE WILLIAM , COSTACHE ADRIANA , KRAWIEC MARIUSZ , FENG YUSHI , TRUDEAU MARTIN
IPC: C07D215/00 , A61K31/00
-
-
-
-
-
-
-
-
-